Beneficial action of statins in patients with rheumatoid arthritis in a large observational cohort

Hiroshi Okamoto1, Kyoko Koizumi, Shigeo Kamitsuji

  • 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan. hokamoto@ior.twmu.ac.jp

Insights

Statins may reduce rheumatoid arthritis (RA) disease activity. This observational study found lower C-reactive protein and fewer swollen joints in RA patients taking statins, suggesting a beneficial role in rheumatology practice.

Area of Science:

  • Rheumatology
  • Pharmacology
  • Clinical Research

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and potential systemic effects.
  • Statins, primarily used for cholesterol management, are being investigated for potential anti-inflammatory properties.
  • Understanding the impact of commonly prescribed medications on RA disease activity is crucial for patient management.

Purpose of the Study:

  • To investigate the association between statin use and disease activity in patients with rheumatoid arthritis (RA).
  • To analyze whether statins offer beneficial effects on RA disease markers in a large observational cohort.

Main Methods:

  • Analysis of cross-sectional data from 4152 RA patients within the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) prospective observational cohort.
  • Comparison of disease activity markers (C-reactive protein, swollen joint counts, patient/physician assessments) between statin users and non-users.
  • Statistical analysis, including Mann-Whitney U-test, with adjustments for corticosteroid use.

Main Results:

  • 6.7% of RA patients (279/4152) were taking statins.
  • Statin users exhibited significantly lower C-reactive protein levels (0.85 vs 1.24 mg/dl) and fewer swollen joint counts (1.80 vs 2.55) compared to non-users.
  • Even after adjusting for corticosteroid dosage, statin use was associated with lower RA disease activity across multiple assessment measures.

Conclusions:

  • The findings suggest that statins possess beneficial effects in mitigating rheumatoid arthritis disease activity.
  • Statin therapy may be a valuable adjunct in the management of RA patients in routine rheumatology care.
  • Further research could explore the mechanisms underlying statins' anti-inflammatory effects in RA.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...